-
News | 2020.03.10
Regulation of metabolic pathways: lessons from an intracellular bacterium
Bacteria that grow inside cells depend on their host cell for access to nutrients. Scientists from the Cellular Biology of Microbial Infection Unit at the Institut Pasteur have discovered that these bacteria exploit the regulation pathways in the host to adapt its metabolism to their own needs and facilitate their proliferation.The enzyme transglutaminase 2 is a protein that can be found in most...
-
Document de presse | 2020.03.10
Cancer: the immune system attacks tumors remotely
How does the immune system act to limit tumor development? Using in vivo imaging tools, scientists from the Institut Pasteur and Inserm described the spatiotemporal activity of tumor-infiltrating T lymphocytes, both locally and remotely. Their research was published in the journal Nature Cancer on March 9, 2020.Some cells in the immune system, like T lymphocytes, are capable of attacking cancer...
-
Article | 2020.03.16
Coronavirus: all COVID-19 news from the Institut Pasteur
On January 9, 2020, Chinese health authorities and the World Health Organization (WHO) officially announced the discovery of a novel coronavirus (first named 2019-nCoV, then officially SARS-CoV-2). This new virus is the pathogen responsible for the infectious respiratory disease called COVID-19 (CoronaVIrus Disease). Following the announcement of the first cases and the declaration of...
-
News | 2020.03.17
Depression and the efficacy of antidepressants depend on the composition of the gut microbiota
Does a healthy microbiota lead to a healthy mind? A joint study between the Institut Pasteur, the CNRS and Inserm has revealed the highly specific profile of the gut bacterial population in a mouse model used to study depression. When the bacterial population is transferred to healthy mice, they exhibit behaviors associated with depression within a few days. This can be explained by the fact that...
-
News | 2020.10.22
Coronavirus: Institut Pasteur warns against false information circulating on social media
-ENGLISH VERSION COMING SOON-Mis à jour le 20 mars 2023.En 2020-2021, lorsque la pandémie de Covid-19 était à son pic, de nombreuses informations circulaient dans les médias, sur les réseaux sociaux, les messageries instantanées, etc. Ces messages ont pu parfois contenir des informations erronées ou s’appuyant sur des propos attribués à tort à des chercheurs de l’Institut Pasteur à...
-
Document de presse | 2020.03.19
CEPI collaborates with the Institut Pasteur in a consortium to develop Covid-19 vaccine
Consortium to be led by the Institut Pasteur and will include Themis and the University of Pittsburgh.CEPI to provide initial US$4.9 million for consortium to develop a Covid-19 vaccine candidate based on measles-vector technology.Partnership becomes eighth Covid-19 vaccine development project that CEPI has signed since Jan 23, 2020 OSLO, NORWAY, March 19, 2020 – CEPI, the Coalition for...
-
Document de presse | 2020.03.20
Editorial: Facing challenges with the novel coronavirus SARS-CoV-2 outbreak
On December 31, 2019, Chinese authorities reported a cluster of pneumonia cases in Wuhan, China, most of which included patients whoreported exposure to a seafood market selling live animals. Emergence of a new pathogenic zoonotic coronavirus (SARS-CoV-2) was suspected. How can we face the challenges with the novel coronavirus SARS-CoV-2 outbreak?Read the editorial of Pr Sylvie van der Werf and...
-
Page avancée | 2020.03.27
Coronavirus SARS-CoV-2 : the Institut Pasteur mobilization
Coronavirus SARS-CoV-2 : the Institut Pasteur mobilization
-
Article | 2020.03.27
Coronavirus (Covid-19) research projects
VACCINE CANDIDATES1. Development of an animal model and accelerated development of a DNA vaccine candidate(SCARD SARS-CoV-2 project)Aims:To develop a mouse model of SARS-CoV-2 infection.This will not only enable us to evaluate the efficacy of the vaccine; it will also facilitate in vivo research on SARS-CoV-2. To evaluate the immunogenicity (ability to induce a specific immune reaction) and...
-
Document de presse | 2020.03.12
Covid-19: 20 research projects selected to fight the epidemic
At a time when the Sars-CoV-2 epidemic is continuing to spread, France is mobilizing to accelerate research into the virus and Covid-19 disease through REACTing – a consortium coordinated by Inserm. With the support of the Ministry of Solidarity and Health and the Ministry of Higher Education, Research and Innovation, the Scientific Advisory Board of REACTing has selected 20 scientific...
